RSS feedwww.statnews.com
ARPA-H to Invest $62 Million in FDA-Authorized AI for Heart Failure CareThe headline reports that ARPA-H will invest $62 million to develop an artificial intelligence system intended to help treat heart failure and obtain authorization from the U.S. Food and Drug Administration. However, the extracted article text is inconsistent with that headline: it consists of a brief about UnitedHealth executives donating to a high-ranking Democrat ahead of the midterm elections and provides no further information about the AI project.
